Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The RITP Study: Rituximab for ITP
NCT00344149Phase 3Completed
- Sponsor
- Ostfold Hospital Trust
- Start
- Jun 2006
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in immune thrombocytopenia (ITP), sponsored by Ostfold Hospital Trust. Started Jun 2006; status: completed.
02
Drugs
rituximab
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00344149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344149.